June 19, 2019 / 6:06 AM / a month ago

BRIEF-Obseva Progressing Toward U.S. Phase 3 Trial For Nolasiban In IVF Following Recent FDA Meeting

June 19 (Reuters) - Obseva SA:

* OBSEVA PROGRESSING TOWARD U.S. PHASE 3 TRIAL FOR NOLASIBAN IN IVF FOLLOWING RECENT FDA MEETING

* COMPANY ANTICIPATES BEGINNING ITS U.S. PHASE 3 CLINICAL TRIAL (IMPLANT 3) IN Q4 OF THIS YEAR OR EARLY 2020

* EXPECT TO SUBMIT IMPLANT 3 TRIAL PROTOCOL WITH AN UPDATED IND IN Q3 OF 2019 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below